2 high yield FTSE 100 dividend shares I’d buy today

Beating the FTSE 100 average is not hard if you know where to look. These high yield dividend shares are also cheap right now, Tom Rodgers says.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

If you’re in the market for high yield FTSE 100 dividend shares then these are the choices I think should be top of your list.

Not every company can support a market-beating dividend with enough cover from its earnings to be sustainable in the long term. In 2019 the FTSE 100 had an average dividend yield of 4.35%.

Some firms will reinvest any surplus to support growth, buy back shares to improve the value of what current shareholders own, or take over profitable, faster-growing rivals to boost their bottom line.

But there are still large, stable multinationals that comfortably outstrip the market average in handing out cash as shareholder dividends.

Shell

For most private investors, choosing investments is a case of waiting for a chance to buy the best FTSE 100 shares when they are not wildly overvalued.

Now could well be that time for Royal Dutch Shell (LSE:RDSB), as its price-to-earnings ratio has dipped under 10.

Shell also supports a whopping 6.7% dividend at last count. While none of us can know the future, I would suggest Shell offers one of the best opportunities for a solid buy-and-hold investment.

The oil giant reported 0.3p earnings per share in 2015, and earnings per share has been on a rocket ride since then. A year later we saw that figure reach 0.58p, then it tripled in 2017 to 1.8p, while 2018 added 55% growth to hit 2.8p.

Looking ahead, a consensus of City analysts have forecast 23% earnings growth in 2020.

Shell chief executive Ben van Buerden will confirm these numbers, as well as the Q4 2019 interim dividend, in results out on 30 January. Buying quality shares ahead of results is normally a solid move for capital appreciation.

GlaxoSmithKline

GlaxoSmithKline (LSE:GSK) has a wide economic moat. It is a market leader in respiratory drugs to treat asthma and medications for HIV. It owns products that none of its rivals can sell, which gives it a clear long-term advantage.

Its three top-selling brands are HIV drugs Triumeq and Tivicay, and prescription asthma medication Advair. Together they contributed to nearly $9bn in sales in 2018.

It would be hard to find a more solid FTSE 100 company, unless the world wakes up one day and stops needing prescription pharmaceuticals.

GSK is also consistently one of the FTSE 100’s largest dividend payers. In five out of the last six years it has featured in the top five, and took sixth place in 2019, only just squeezed out thanks to a surprise $1bn special dividend from mining giant Rio Tinto.

GSK’s 2019 dividend is also paid like clockwork. 2014’s yield was 5.8% with 19p per share paid per quarter and 23p paid in Q4. The same exact payments continued in 2015 (plus a 20p per share special dividend), in 2016, 2017, and 2018 on a dividend cover growing to 1.5 in 2018.

While many early-stage private investors seek their fortunes in long-shot unprofitable gold miners, or speculative AIM shares with patchy histories, the highest-yielding FTSE 100 shares — with investments allowed to compound over time — are the simplest way to make yourself richer and your portfolio larger.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Tom Rodgers owns shares in GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »